Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00279409 · ClinicalTrials.gov registry record · Phase 2
Treatment of Children With ADHD Who do Not Fully Respond to Stimulants
A Phase 2 study, sponsored by New York State Psychiatric Institute.
- Terminated
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT00279409 is a Phase 2 study that was terminated before completion, run by New York State Psychiatric Institute. The registered enrollment target is 10 participants.
The verdict
NCT00279409, a Phase 2 study, was terminated before completion, sponsored by New York State Psychiatric Institute.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this pilot is to initiate a program of research into the development of effective medication techniques to treat those children with ADHD who are referred because they are "partial" or "non-responders" to standard stimulant treatment.
Interventions
- DRUG Sugar pill
- DRUG aripiprazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2006-07 |
| Est. Completion | 2009-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00279409
The ClinicalTrials.gov registry entry for NCT00279409 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sugar pill is the first listed.
NCT00279409 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00279409 about?
NCT00279409 is a clinical study titled "Treatment of Children With ADHD Who do Not Fully Respond to Stimulants". The purpose of this pilot is to initiate a program of research into the development of effective medication techniques to treat those children with ADHD who are referred because they are "partial" or "non-responders" to standard stimulant treatment.
What is the current status of trial NCT00279409?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2006-07. Estimated completion is 2009-02.
What interventions are being tested in trial NCT00279409?
The interventions under investigation include: Sugar pill (DRUG), aripiprazole (DRUG).
Who is sponsoring clinical trial NCT00279409?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.